Navigation Links
Century Park Capital Partners Announces the Recapitalization of Cirtec Medical Systems, LLC
Date:1/6/2011

LOS ANGELES, Jan. 6, 2011 /PRNewswire/ -- Century Park Capital Partners is pleased to announce that it led the recapitalization of Cirtec Medical Systems, LLC ("Cirtec") along with Charter Oak Equity and the company's founders. Cirtec is a leading provider of client focused, comprehensive medical product design, engineering and manufacturing solutions.  Cirtec provides its customers with highly technical solutions, utilizing its expertise in minimally invasive systems, active and passive implants, and medical electronics. Cirtec was formed in 2009 from the merger of Circle Medical Devices and Texcel Medical.  The company operates out of locations in Los Gatos, California and East Longmeadow, Massachusetts.  

"We chose to partner with Century Park because of their philosophy of collaborating with management and their track record of successfully helping businesses grow," stated Barry Smith, CEO of Cirtec. "Century Park's leadership and access to resources will allow us to maintain our industry leading position in the outsourced medical device design and manufacturing industry as we take our business to the next level."

Larry Derose, one of the founders of the company said, "This partnership with Century Park is the next step in our company's evolution.  By coupling our success in the market with Century Park's proven experience helping businesses of our size grow, we have become exceptionally well positioned to capture the tremendous opportunities that exist in our marketplace."

Century Park Capital Partners has experienced success in the medical device arena through prior investments in the medical contract manufacturing sector.

Chip Roellig, a Managing Partner of Century Park, stated, "We are very enthusiastic about our new partnership with Cirtec. Cirtec's reputation as the market leader and its customer relationships with major medical device OEMs in the neurostimulation and cardiovascular markets set the company apart from other medical device design and manufacturing firms. Cirtec is especially attractive because they offer their customers a range of highly technical capabilities that improve device design and reduce time to market for new devices, while offering a superior economic value proposition. Furthermore, Cirtec is well positioned to take advantage of the trend in increased outsourcing of medical device design and manufacturing.  As neurostimulation and cardiovascular devices evolve and gain further acceptance, Cirtec is primed for growth."

Terms of the transaction were not disclosed. The investment by Century Park was made from its latest fund, Century Park Capital Partners II, L.P.  

About Cirtec Medical Systems

Cirtec Medical Systems, through its partnerships with its customers, has become a leading single-source provider of comprehensive medical product design and manufacturing solutions from concept through high-volume finished goods across all therapeutic categories. Its technically-driven, 130-person team has particular expertise in minimally invasive systems, active and passive implants, and medical electronics.  Cirtec Medical Systems is ISO-13485 (2003) and FDA certified and maintains locations in Los Gatos, California and East Longmeadow, Massachusetts.  For more information about Cirtec, please visit www.cirtecmed.com.

About Century Park Capital Partners

Century Park Capital Partners is a Los Angeles-based private equity firm that partners with owner/managers to build successful companies. The firm specializes in facilitating owner liquidity and business expansion by providing equity for recapitalizations, buyouts, growth financings, and acquisitions. More information on Century Park Capital Partners can be found at www.centuryparkcapital.com.

About Charter Oak Equity

Charter Oak Equity is a Westport, CT based private equity firm.  Charter Oak Equity focuses on niche manufacturing, packaging, medical products & services, specialty chemicals, consumer products and financial services companies ranging in size from $5 million to $150 million in enterprise value.   More information on Charter Oak Equity can be found at www.charteroak-equity.com.


'/>"/>
SOURCE Century Park Capital Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Back Braces and Wrap-Arounds Move Into the 21st Century
2. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
3. Omeros to Present at the BioCentury NewsMakers Conference
4. BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry Conference
5. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
6. Sucrets(R) ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season
7. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
8. Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers
9. St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels
10. Michigan Pre-Seed Capital Fund Reports Investments Totaling $2.5 Million in 2010
11. PneumRx, Inc. Raises $33 Million in Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ON , Feb. 10, 2016 /PRNewswire/ - The ... , has announced the release of an anti-radiation ... is a revolutionary breakthrough in the treatment of ... radiation exposure. It will assist in the healing ... present. It will also protect only the healthy ...
(Date:2/10/2016)... KANSAS CITY, Mo. , Feb. 10, 2016 ... the pharmaceutical industry, recently identified an industry-wide trend ... a tool that allows organizations to efficiently deliver ... surveys, one in 2011 and another in 2015, ... are armed with tablet devices and DSAs, many ...
(Date:2/10/2016)... Feb. 9, 2016 CTI BioPharma Corp. ... an update regarding the clinical studies being conducted ... for pacritinib. Following the issuance of the Company,s ... clinical hold issued by the U.S. Food and ... Company received an oral communication from the FDA ...
Breaking Medicine Technology:
(Date:2/10/2016)... , ... February 10, 2016 , ... ... together to expand dental health services to the developmentally disabled in the Coachella ... Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, in ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intermedix announced ... Emergency Medicine , an emergency medicine professional association, to support the organization's newly ... The American Academy of Emergency Medicine, or AAEM, seeks to empower emergency physicians ...
(Date:2/10/2016)... SAN FRANCISCO, Calif. (PRWEB) , ... February 10, 2016 , ... ... category: Best Water Brand. There were three leading bottled water brand owners that topped ... edge services that enhance connectivity and optimize conversion. The premier brand was Tibet 5100, ...
(Date:2/10/2016)... Louis, Missouri (PRWEB) , ... February 10, 2016 ... ... 2016, in San Diego, will bring together more than 200 of the country’s ... healthcare for the future. , “The true benefit of the Forum is the ...
(Date:2/10/2016)... ... , ... Armune BioScience signed a definitive agreement with ARCpoint ... across the country. Launched in April of 2015, Apifiny is the only cancer specific, ... order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized ...
Breaking Medicine News(10 mins):